Clinical Trial of Blinatumomab in Refractory/Active Systemic Lupus Erythematosus in Children
Latest Information Update: 31 Jan 2025
Price :
$35 *
At a glance
- Drugs Blinatumomab (Primary)
- Indications Systemic lupus erythematosus
- Focus Adverse reactions
- Acronyms BRASLE
- 31 Jan 2025 New trial record